DE69230225T2 - Triazolylierte tertiäre aminverbindungen oder ihre salze - Google Patents

Triazolylierte tertiäre aminverbindungen oder ihre salze

Info

Publication number
DE69230225T2
DE69230225T2 DE69230225T DE69230225T DE69230225T2 DE 69230225 T2 DE69230225 T2 DE 69230225T2 DE 69230225 T DE69230225 T DE 69230225T DE 69230225 T DE69230225 T DE 69230225T DE 69230225 T2 DE69230225 T2 DE 69230225T2
Authority
DE
Germany
Prior art keywords
group
amino
triazole
ring
optionally substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69230225T
Other languages
German (de)
English (en)
Other versions
DE69230225D1 (de
Inventor
Yasuo Isomura
Eiji Kawaminami
Masafumi Kudou
Minoru Okada
Toru Yoden
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Astellas Pharma Inc
Original Assignee
Yamanouchi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamanouchi Pharmaceutical Co Ltd filed Critical Yamanouchi Pharmaceutical Co Ltd
Application granted granted Critical
Publication of DE69230225D1 publication Critical patent/DE69230225D1/de
Publication of DE69230225T2 publication Critical patent/DE69230225T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Treatments Of Macromolecular Shaped Articles (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
  • Cosmetics (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DE69230225T 1991-09-02 1992-08-27 Triazolylierte tertiäre aminverbindungen oder ihre salze Expired - Fee Related DE69230225T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP24826891 1991-09-02
JP34401191 1991-12-02
PCT/JP1992/001089 WO1993005027A1 (fr) 1991-09-02 1992-08-27 Amine tertiaire triazolylee ou un sel de celle-ci

Publications (2)

Publication Number Publication Date
DE69230225D1 DE69230225D1 (de) 1999-12-02
DE69230225T2 true DE69230225T2 (de) 2000-05-31

Family

ID=26538684

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69230225T Expired - Fee Related DE69230225T2 (de) 1991-09-02 1992-08-27 Triazolylierte tertiäre aminverbindungen oder ihre salze

Country Status (20)

Country Link
US (1) US5674886A (enExample)
EP (1) EP0641785B1 (enExample)
KR (1) KR100204697B1 (enExample)
CN (1) CN1035817C (enExample)
AT (1) ATE186052T1 (enExample)
AU (1) AU665569B2 (enExample)
BG (1) BG61688B1 (enExample)
CA (1) CA2116773C (enExample)
DE (1) DE69230225T2 (enExample)
ES (1) ES2139605T3 (enExample)
FI (1) FI940988L (enExample)
HU (1) HU220863B1 (enExample)
MX (1) MX9204996A (enExample)
NO (1) NO305284B1 (enExample)
PT (1) PT100821B (enExample)
RO (1) RO114129B1 (enExample)
RU (1) RU2124010C1 (enExample)
TW (1) TW225526B (enExample)
UA (1) UA41295C2 (enExample)
WO (1) WO1993005027A1 (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5770616A (en) 1995-06-07 1998-06-23 The Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of cancers
RU2131422C1 (ru) * 1997-05-21 1999-06-10 Иван Антонович Мазур Бромид 1-пентил-4-(п-метоксибензилиденамино)-1,2,4-триазолия, проявляющий спазмолитическую активность
US7022702B2 (en) * 2000-04-07 2006-04-04 Qlt Inc. Antiproliferative 1,2,3-thiadiazole compounds
US6420400B1 (en) 2000-04-07 2002-07-16 Kinetek Pharmaceuticals, Inc. Antiproliferative 1,2,3-thiadiazole compounds
IL156584A0 (en) * 2000-12-22 2004-01-04 Ortho Mcneil Pharm Inc Substituted triazole diamine derivatives as kinase inhibitors
GB0120147D0 (en) * 2001-08-17 2001-10-10 Metris Therapeutics Ltd Treatment method
GB0127923D0 (en) 2001-11-21 2002-01-16 Sterix Ltd Compound
WO2003045925A1 (en) * 2001-11-21 2003-06-05 Sterix Limited 1,2,4-triazole derivatives containing a sulphamate group as aromatase inhibitors
JP2004196795A (ja) * 2002-12-16 2004-07-15 Wyeth 外部寄生虫駆除剤としてのｎ−フェニル−３−シクロプロピルピラゾール−４−カルボニトリル
EP1431292A1 (en) * 2002-12-16 2004-06-23 Laboratoire Theramex 1-N-phenylamino-1H-imidazole derivatives as aromatase inhibitors
AU2011226950B9 (en) * 2003-12-15 2013-04-11 Laboratoire Theramex 1-N-phenyl-amino-1H-imidazole derivatives and pharmaceutical compositions containing them
US8476455B2 (en) 2003-12-15 2013-07-02 Laboratoire Theramex 1-N-phenyl-amino-1h-imidazole derivatives and pharmaceutical compositions containing them
EP1544195A1 (en) * 2003-12-15 2005-06-22 Laboratoire Theramex 1-N-phenyl-amino- 1H-imidazole derivatives and pharmaceutical compositions containing them
GB0411562D0 (en) * 2004-05-24 2004-06-23 Sterix Ltd Compound
JP5777163B2 (ja) * 2009-07-03 2015-09-09 国立研究開発法人理化学研究所 Ｐｅｔ用標識化合物
GB0914767D0 (en) * 2009-08-24 2009-09-30 Sterix Ltd Compound
CN113387894B (zh) * 2021-06-22 2023-02-24 首都医科大学脑重大疾病研究中心(北京脑重大疾病研究院) 1-n-苯乙腈基氨基-三氮唑和嘧啶衍生物及其制备方法和应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2488891A1 (fr) * 1980-08-22 1982-02-26 Roussel Uclaf Nouveaux derives du 4h-1,2,4-triazole, leur procede de preparation et leur application comme medicament
DE3410700A1 (de) * 1984-03-23 1985-09-26 Basf Ag, 6700 Ludwigshafen 2,4,5-triphenyl-v-triazole und deren verwendung
US4602025A (en) * 1984-06-18 1986-07-22 Eli Lilly And Company Aromatase inhibitors
US4609666A (en) * 1984-06-18 1986-09-02 Eli Lilly And Company Aromatase inhibiting derivatives of α,α-bis(4-halophenyl)methyltetrazoles and triazoles
US4661508A (en) * 1984-06-18 1987-04-28 Eli Lilly And Company Aromatase inhibiting α,α-diphenyl-4(5)imidazole-methanes or -ethanes
US4749713A (en) 1986-03-07 1988-06-07 Ciba-Geigy Corporation Alpha-heterocycle substituted tolunitriles
CH677925A5 (enExample) * 1986-12-03 1991-07-15 Sandoz Ag
US5041458A (en) * 1987-03-20 1991-08-20 E. I. Du Pont De Nemours And Company Fungicidal aminotriazoles and aminoimidazoles
EP0349580B1 (en) * 1987-03-20 1991-05-15 E.I. Du Pont De Nemours And Company Fungicidal aminotriazoles and aminoimidazoles
NZ224714A (en) * 1987-06-01 1990-03-27 Janssen Pharmaceutica Nv Substituted benzotriazole derivatives and pharmaceutical compositions
US4806554A (en) * 1988-01-11 1989-02-21 Hoechst-Roussel Pharmaceuticals, Inc. Pyrazol and indazolpyridinamines
GR900100380A (el) * 1989-05-20 1991-10-10 Fisons Plc Μέ?οδος παρασκευής αντι-φλεγμονωδών παραγώγων αμινοφενόλης.

Also Published As

Publication number Publication date
FI940988A7 (fi) 1994-04-05
ES2139605T3 (es) 2000-02-16
BG61688B1 (bg) 1998-03-31
CA2116773C (en) 2002-12-10
FI940988A0 (fi) 1994-03-02
AU665569B2 (en) 1996-01-11
ATE186052T1 (de) 1999-11-15
KR100204697B1 (ko) 1999-06-15
FI940988L (fi) 1994-04-05
RO114129B1 (ro) 1999-01-29
HU9400611D0 (en) 1994-09-28
CN1035817C (zh) 1997-09-10
EP0641785A4 (en) 1994-06-16
US5674886A (en) 1997-10-07
CN1069974A (zh) 1993-03-17
NO940686D0 (no) 1994-02-28
AU2487492A (en) 1993-04-05
PT100821B (pt) 1999-07-30
EP0641785A1 (en) 1995-03-08
PT100821A (pt) 1993-11-30
BG98618A (bg) 1995-03-31
EP0641785B1 (en) 1999-10-27
CA2116773A1 (en) 1993-03-18
DE69230225D1 (de) 1999-12-02
RU2124010C1 (ru) 1998-12-27
MX9204996A (es) 1993-08-01
TW225526B (enExample) 1994-06-21
HU220863B1 (en) 2002-06-29
NO305284B1 (no) 1999-05-03
NO940686L (enExample) 1994-04-29
HUT67249A (en) 1995-03-28
WO1993005027A1 (fr) 1993-03-18
UA41295C2 (uk) 2001-09-17

Similar Documents

Publication Publication Date Title
DE69230225T2 (de) Triazolylierte tertiäre aminverbindungen oder ihre salze
DE69319380T2 (de) Azolverbindungen, deren Herstellung und Verwendung
EP0268148B1 (de) Tetrahydronaphthalinderivate und diese enthaltende Arzneimittel
EP1765788B1 (de) 3-aminoindazole derivate und ihre verwendung zur behandlung sgk-bedingten krankheiten
DE69830403T2 (de) Inhibitoren des faktors xa mit einer neutralen gruppe mit p1-spezifität
DE69717627T2 (de) N-4-(heteroarylmethyl)phenyl-heteroarylaminderivate
DE69728673T2 (de) Substituierte biphenylisoxazolsulfonamide
DE69524246T2 (de) 1,2,3,4-Tetrahydroquinoxalindion Derivate und ihre Verwendung als Glutamat Rezeptor Antagonisten
DE69324141T2 (de) Substituierte tertiäre amine und deren salze
DD149525A5 (de) Verfahren zur herstellung von indol-derivaten
DE69413019T2 (de) Stickstoff enthaltende kondensierte heterocylen
DE69323667T2 (de) 4-substituierte 1,2,4-Triazolderivate
DE69329942T2 (de) Antidepressiv wirkende 3-Halophenylpiperazinyl-Propylderivate von substituierten Triazolonen und Triazoldionen
JPWO1993022290A1 (ja) 新規置換３級アミノ化合物又はその塩
EP1124809A1 (de) Benzoylpyridazine
DE3445691A1 (de) Amidinderivate, verfahren zu ihrer herstellung und pharmazeutische mittel
WO2001047896A1 (de) Benzimidazole, deren herstellung und deren verwendung als antithrombotika
DE69424215T2 (de) Verfahren zur Herstellung von 1-(1,2,4-Triazol-1-yl)-propan-2-ol-Derivaten
JP2500849B2 (ja) トリアゾリル置換３級アミノ化合物又はその塩
EP0006542A2 (de) Verwendung des N-Dichloracetyl-1,2,3,4-tetrahydroisochinolins als Gegenmittel zum Schutz von Kulturpflanzen vor Schädigungen durch herbizid-wirksame Acetanilide; die so erhaltenen Kombinationen und Verfahren zu deren Herstellung
DE69110219T2 (de) 3-(1H-Indazol-3-yl)-4-pyridiname, Verfahren und Zwischenprodukte zu ihrer Herstellung und ihre Verwendung als Arzneimittel.
EP0110298B1 (de) Acridanon-Derivate
EP0037471B1 (de) 1-Aroyl-2-phenylamino-2-imidazoline, ihre Herstellung und diese enthaltende Arzneimittel
JPWO1993005027A1 (ja) トリアゾリル置換３級アミノ化合物又はその塩
DE69318869T2 (de) Pyrazolo(3,4-a)acridinderivate als Analgetika

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: ASTELLAS PHARMA INC., TOKIO/TOKYO, JP

8339 Ceased/non-payment of the annual fee